Skip to main content
ELV
NYSE Life Sciences

Elevance Health 第一季度调节后每股收益超出预期 1.78 美元，提升全年指导

feedReported by Reuters
Sentiment info
Positive
Importance info
8
Price
$340
Mkt Cap
$72.074B
52W Low
$273.71
52W High
$432.934
Market data snapshot near publication time

summarizeSummary

Elevance Health 公布了强劲的第一季度业绩，调节后每股收益（EPS）为 12.58 美元，大幅超出 IBES 估计的 10.80 美元。这一强劲的超预期表现表明公司的运营表现优于预期。该公司还将全年的调节后每股收益预期上调至 26.75 美元，超过了 25.70 美元的共识估计，表明公司对持续动力充满信心。这一积极的收益惊喜和对指导的上调对于交易者来说具有高度的重要性，可能会引发积极的股票走势和分析师的升级。

在该公告发布时，ELV的交易价格为$340.00，交易所为NYSE，所属行业为Life Sciences，市值约为$720.7亿。 52周交易区间为$273.71至$432.93。 这则新闻被评估为积极市场情绪，重要性评分为8/10。 来源：Reuters。

show_chartPrice Chart

Share this article

Copied!

feed ELV - Latest Insights

ELV
Apr 22, 2026, 10:09 AM EDT
Filing Type: 10-Q
Importance Score:
8
Elevance Health Reports Q1 GAAP EPS Decline and $935M Regulatory Accrual
Sentiment: Negative
View Wiseek Article
ELV
Apr 22, 2026, 6:02 AM EDT
Filing Type: 8-K
Importance Score:
8
Elevance Health Beats Q1 EPS, Raises Full-Year Guidance Despite $935M CMS Accrual
Sentiment: Positive
View Wiseek Article
ELV
Apr 22, 2026, 6:00 AM EDT
Source: Reuters
Importance Score:
8
Elevance Health Beats Q1 Adjusted EPS by $1.78, Boosts Full-Year Guidance
Sentiment: Positive
View Wiseek Article
ELV
Mar 10, 2026, 6:10 AM EDT
Source: Reuters
Importance Score:
7
Elevance Health Reaffirms FY2026 EPS Guidance of At Least $25.50, Including CMS Sanctions Impact
Sentiment: Neutral
View Wiseek Article
ELV
Mar 10, 2026, 6:02 AM EDT
Filing Type: 8-K
Importance Score:
7
Elevance Health Reaffirms 2026 Earnings Guidance Despite Medicare Sanctions
Sentiment: Neutral
View Wiseek Article
ELV
Mar 02, 2026, 6:13 AM EST
Source: Unknown
Importance Score:
8
CMS Threatens to Suspend Elevance Health's MA-PD Enrollment Over Risk-Adjustment Issues
Sentiment: Negative
View Wiseek Article
ELV
Mar 02, 2026, 6:03 AM EST
Filing Type: 8-K
Importance Score:
8
CMS Imposes Sanctions on Elevance Health, Suspending Medicare Advantage Enrollment
Sentiment: Negative
View Wiseek Article
ELV
Feb 26, 2026, 2:59 PM EST
Filing Type: 8-K
Importance Score:
7
Elevance Health Announces Executive Leadership Changes, Reaffirms FY26 Guidance
Sentiment: Neutral
View Wiseek Article
ELV
Feb 06, 2026, 2:57 PM EST
Filing Type: 10-K
Importance Score:
7
Elevance Health Reports Mixed FY25 Results with Profit Decline and Significant Regulatory Headwinds
Sentiment: Negative
View Wiseek Article
ELV
Jan 28, 2026, 6:03 AM EST
Filing Type: 8-K
Importance Score:
8
Elevance Health Reports Q4 & FY25 Results; Issues Significantly Lower FY26 EPS & Revenue Guidance
Sentiment: Negative
View Wiseek Article